• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Donald P. Goldstein, MD


  • Worley MJ, Joseph NT, Berkowitz RS, Goldstein DP.Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.Int J Gynecol Cancer. 2014 Jun;24(5):941-5.
  • Maestá I, Growdon WB, Goldstein DP, Bernstein MR, Horowitz NS, Rudge MV, Berkowitz RS.Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.Gynecol Oncol. 2013 Aug;130(2):312-6.
  • Berkowitz RS, Goldstein DP.Current advances in the management of gestational trophoblastic disease.Gynecol Oncol. 2012 Jul 27.
  • Rauh-Hain JA, Growdon WB, Braga A, Goldstein DP, Berkowitz RS.Gestational trophoblastic neoplasia in adolescents.J Reprod Med.;57(5-6):237-42.
  • Braga A, Growdon WB, Bernstein M, Maestá I, Rudge MV, Goldstein DP, Berkowitz RS.Molar pregnancy in adolescents.J Reprod Med.;57(5-6):225-30.
  • Shah NT, Barroilhet L, Berkowitz RS, Goldstein DP, Horowitz N.A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.J Reprod Med.;57(5-6):211-8.
  • Goldstein DP.The past is prologue to the present: Milestones in the modern management of molar pregnancy and gestational trophoblastic neoplasia.J Reprod Med.;57(5-6):189-96.
  • Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS.Complete hydatidiform mole in women aged 40 to 49 years.J Reprod Med.;57(5-6):254-8.
  • Rodriguez N, Goldstein DP, Berkowitz RS.Treating gestational trophoblastic disease.Expert Opin Pharmacother. 2010 Dec;11(18):3027-39.
  • Growdon WB, Wolfberg AJ, Goldstein DP, Feltmate CM, Chinchilla ME, Lieberman ES, Berkowitz RS.Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.J Reprod Med.;55(7-8):279-84.
  • Elias KM, Goldstein DP, Berkowitz RS.Complete hydatidiform mole in women older than age 50.J Reprod Med.;55(5-6):208-12.
  • Clark RM, Nevadunsky NS, Ghosh S, Goldstein DP, Berkowitz RS.The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.J Reprod Med.;55(5-6):194-8.
  • Goldstein DP.Gestational trophoblastic neoplasia: where we came from, where we stand today, where we are heading. Keynote address.J Reprod Med.;55(5-6):184-93.
  • Seckl MJ, Savage PM, Hancock BW, Berkowitz RS, Goldstein DP, Lurain JR, Schink JC, Cagayan FM, Golfier F, Ngan H, Wake N, Osborne R, Sasaki S, Charry RC, Wong LC, Sekharan PK, Djamhoer MA, Massuger L, Belfort P, Kim SJ, Lee C, Jung SG."Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".Gynecol Oncol. 2010 Jun;117(3):505-6; author reply 506-7.
  • Berkowitz RS,Goldstein DP.Clinical practice. Molar pregnancy.N Engl J Med. 2009 Apr 16;360(16):1639-45. Review.
  • Horowitz NS,Goldstein DP,Berkowitz RS.Management of gestational trophoblastic neoplasia.Semin Oncol. 2009 Apr;36(2):181-9. Review.
  • Growdon WB,Wolfberg AJ,Goldstein DP,Feltmate CM,Chinchilla ME,Lieberman ES,Berkowitz RS.Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.Gynecol Oncol. 2009 Feb;112(2):353-7.
  • Sawka AM, Lakra DC, Lea J, Alshehri B, Tsang RW, Brierley JD, Straus S, Thabane L, Gafni A, Ezzat S, George SR, Goldstein DP.A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.Clin Endocrinol (Oxf). 2008 Sep;69(3):479-90. Review.
  • Berkowitz RS,Goldstein DP.Current management of gestational trophoblastic diseases.Gynecol Oncol. 2009 Mar;112(3):654-62. Review.
  • Fleming EL,Garrett L,Growdon WB,Callahan M,Nevadunsky N,Ghosh S,Goldstein DP,Berkowitz RS.The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center.J Reprod Med. 2008 Jul;53(7):493-8.
  • Garrett LA,Garner EI,Feltmate CM,Goldstein DP,Berkowitz RS.Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia.J Reprod Med. 2008 Jul;53(7):481-6.
  • Berkowitz RS,Goldstein DP.Gestational trophoblastic disease: presentations from the XLVTH World Congress on Gestational Trophoblastic Diseases.J Reprod Med. 2008 Jul;53(7):455-6.
  • Moukarbel RV, Goldstein DP, O'Sullivan B, Gullane PJ, Brown DH, Wang L, Irish JC.Adenoid cystic carcinoma of the larynx: A 40-year experience.Head Neck. 2008 Jul;30(7):919-24.
  • Goldstein DP, Karnell LH, Yao M, Chamberlin GP, Nguyen TX, Funk GF.Outcomes following reirradiation of patients with head and neck cancer.Head Neck. 2008 Jun;30(6):765-70.
  • Lee A, Goldstein DP, Irish J, Gentili F, Perez-Ordonez B.Noncontiguous bilateral esthesioneuroblastoma: a case report.Skull Base. 2007 Nov;17(6):405-7.
  • Sawka AM, Goldstein DP, Thabane L, Brierley JD, Tsang RW, Rotstein L, Kamalanathan S, Zhao B, Gafni A, Straus S, Ezzat S.Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.Endocr Pract. 2008 Mar;14(2):175-84.
  • Shrime MG, Goldstein DP, Seaberg RM, Sawka AM, Rotstein L, Freeman JL, Gullane PJ.Cost-effective management of low-risk papillary thyroid carcinoma.Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1245-53. Review.
  • Subramanian S, Goldstein DP, Parlea L, Thabane L, Ezzat S, Ibrahim-Zada I, Straus S, Brierley JD, Tsang RW, Gafni A, Rotstein L, Sawka AM.Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis.Thyroid. 2007 Dec;17(12):1277-88. Review.
  • Sawka AM, Rotstein L, Brierley JD, Tsang RW, Thabane L, Gafni A, Straus S, Kamalanathan S, Zhao B, Goldstein DP, Rambaldini G, Ezzat S.Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.Thyroid. 2007 Dec;17(12):1235-42.
  • Sawka AM, Lea J, Alshehri B, Straus S, Tsang RW, Brierley JD, Thabane L, Rotstein L, Gafni A, Ezzat S, Goldstein DP.A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors.Clin Endocrinol (Oxf). 2008 Apr;68(4):610-7.
  • Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS.Gestational trophoblastic disease.Clin Obstet Gynecol. 2007 Mar;50(1):112-22. Review.
  • Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.J Reprod Med. 2006 Nov;51(11):871-4.
  • Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS.Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.J Reprod Med. 2006 Nov;51(11):902-6.
  • Wolfberg AJ, Growdon WB, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES.Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.Obstet Gynecol. 2006 Aug;108(2):393-6.
  • Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS.The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.Gynecol Oncol. 2005 Oct;99(1):3-5.
  • Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.Obstet Gynecol. 2005 Sep;106(3):548-52.
  • Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, Kluhsman BC, Osann K, Newlands E, Seckl MJ, Hancock B, Cella D.Defining and measuring reproductive concerns of female cancer survivors.J Natl Cancer Inst Monogr. 2005(34):94-8.
  • Garner E, Goldstein DP, Berkowitz RS, Wenzel L.Psychosocial and reproductive outcomes of gestational trophoblastic diseases.Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):959-68.
  • Feltmate CM, Batorfi J, Fulop V, Goldstein DP, Doszpod J, Berkowitz RS.Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.Obstet Gynecol. 2003 Apr;101(4):732-6.
  • Garner EI, Meyerovitz M, Goldstein DP, Berkowitz RS.Successful term pregnancy after selective arterial embolization of symptomatic arteriovenous malformation in the setting of gestational trophoblastic tumor.Gynecol Oncol. 2003 Jan;88(1):69-72.
  • Genest DR, Ruiz RE, Weremowicz S, Berkowitz RS, Goldstein DP, Dorfman DM.Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens.J Reprod Med. 2002 May;47(5):363-8.
  • Wenzel L, Berkowitz RS, Newlands E, Hancock B, Goldstein DP, Seckl MJ, Habbal R, Bernstein M, Kluhsman B, Kulchak-Rahm A, Strickland S, Higgins J.Quality of life after gestational trophoblastic disease.J Reprod Med. 2002 May;47(5):387-94.
  • Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS.Advances in the understanding of placental site trophoblastic tumor.J Reprod Med. 2002 May;47(5):337-41.
  • Garner EI, Lipson E, Bernstein MR, Goldstein DP, Berkowitz RS.Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor.J Reprod Med. 2002 May;47(5):380-6.
  • Garrett AP, Garner EO, Goldstein DP, Berkowitz RS.Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.J Reprod Med. 2002 May;47(5):355-62.
  • Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS.Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center.Gynecol Oncol. 2001 Sep;82(3):415-9.
  • Berkowitz RS, Tuncer ZS, Bernstein MR, Goldstein DP.Management of gestational trophoblastic diseases: subsequent pregnancy experience.Semin Oncol. 2000 Dec;27(6):678-85.
  • Benson CB, Genest DR, Bernstein MR, Soto-Wright V, Goldstein DP, Berkowitz RS.Sonographic appearance of first trimester complete hydatidiform moles.Ultrasound Obstet Gynecol. 2000 Aug;16(2):188-91.
  • Goldstein DP, Berkowitz RS.Current management of complete and partial molar pregnancy.J Reprod Med. 1994 Mar;39(3):139-46.
  • Goldstein DP, Aono T, Taymor ML, Jochelson K, Todd R, Hines E.Radioimmunoassay of serum chorionic gonadotropin activity in normal pregnancy.Am J Obstet Gynecol. 1968 Sep 1;102(1):110-4.